versión impresa ISSN 0123-3475
Rev. colomb. biotecnol v.13 n.1 Bogotá ene./jun. 2011
ARTÍCULO DE INVESTIGACIÓN
The genomic identification of Colombian Acinetobacter baumannii clinical isolates by RFLP-PCR analysis of the 16S-23S rRNA gene spacer region
Identificación genómica de aislamientos colombianos de Acinetobacter baumannii mediante RFLP-PCR de la región intergénica espaciadora de los genes 16S y 23S rRNA
María Andrea Hernández 1,2 , Emilia María Valenzuela 2 , Ingrid Yamile Pulido 2 , María Teresa Reguero 2 , Silvia Restrepo 1 , Sandra Gualtero Trujillo 3 , Dagoberto Santofimio Sierra , Martha Ramirez Plazas 4 , Luz Eneida Quintero 5 , José Ramón Mantilla 2*.
1 Mycology and Phytopathology Laboratory, Universidad de los Andes, Bogotá-Colombia
2 Instituto de Biotecnología, Universidad Nacional, Bogotá, Colombia
3 Fundación Clínica Abbod Shaio, Bogotá, Colombia
4 Facultad de Salud Pública, Universidad Surcolombiana
5 Hernando Moncaleano Perdomo Teaching Hospital
* Corresponding author: mailing address: Carrera 30 No 45-03, Universidad Nacional de Colombia, Bogotá, Colombia e-mail: firstname.lastname@example.org
Recibido: septiembre 10 de 2010 Aprobado: mayo 30 de 2011
The 16S-23S rRNA gene intergenic spacer (ITS) was analysed by RFLP in this study to identify A. baumannii from 139 isolates from four hospitals (identified as A, B, C and D). One hundred and twenty of these isolates (86.3%) belonged to the A. baumannii species; those identified as being A. baumannii were found to be polyclonal (19 clone groups) when determining the genetic relationships, 16 of them being found in hospital C. Hospitals A, B and D shared two clone groups isolated during different years. This study describes a rapid and easy method for genospecies identification of Acinetobacter baumannii.
Key words: Acinetobacter baumannii-Acinetobacter calcoaceticus complex; 16S-23S rRNA gene intergenic spacer (ITS); RFLP-PCR.
Con el objeto de identificar la genomoespecie Acinetobacter baumannii, se estudiaron 189 aislamientos pertenecientes al Complejo Acinetobacter baumannii-Acinetobacter calcoaceticus provenientes de cuatro hospitales colombianos (denominados A,B,C,D) mediante el análisis por RFLP-PCR de la región intergénica espaciador (ITS) de los genes 16S y 23S rRNA. Se encontraron 120 aislamientos (86.3%) pertenecientes a la especie A. baumannii. La estructura de la población fue policlonal, con 19 grupos clonales, 16 de los cuales se hallaron en el hospital C. En los hospitales A,B y D se encontraron 2 grupos clonales aislados durante diferentes años. En este estudio se propone un método rápido y fácil para la identificación de Acinetobacter baumannii
Palabras clave: Complejo Acinetobacter baumannii-Acinetobacter calcoaceticus; Región intergénica espaciadora (ITS), RFLP-PCR.
Different Acinetobacter species have been well characterised as being a major public health concern as they have been responsible for well-characterised epidemic outbreaks all around the world (1, 4, 31). Hybridisation studies have shown that the Acinetobacter genus is biochemically and genetically heterogeneous. Thirty-three genomic species (genospecies) have been shown to belong to this genus to date (3, 4, 31). Due to the close phenotypic and genetic relationship between genospecies 1 (A. calcoaceticus), 2 (A. baumannii), 3 and 13TU and the difficulties hampering dividing them by classical biochemical reactions, genospecies1, 2, 3 and 4 have been reported as being A. baumannii-A. calcoaceticus complex or as A. baumannii as the biochemical differences between these four species are subtle and no commercial automated identification systems are capable of discriminating within the A. baumannii-A. calcoaceticus complex. However, A. baumannii remains mainly responsible for outbreaks sensu stricto (1, 4, 13, 31).
Epidemiological studies have demonstrated the usefulness of being able to distinguish the species from the complex (35); accurately identifying species within the A. baumannii-A. calcoaceticus complex is therefore important for elucidating these species’ ecology, epidemiology and pathology (4, 16, 17, 31). Several genetic methods have been developed for genomic species identification within the A. baumannii-A. calcoaceticus complex; these methods include amplified rDNA, restriction analysis (ARDRA), ribosomal operon analysis, recA gene and /or rpoB gene sequencing and 16S-23S rRNA gene intergenic spacer analysis (4, 6, 11, 19, 25, 27). The latter approach has shown that the intergenic spacer (ITS) region sequence between the 16S and 23S rRNA genes has low intraspecies variation and high levels of interspecies divergence (5). This region could thus lead to identifying species within the same genus due to variability in both length and sequence (10, 18, 26, 32).
Although several epidemiological reports have analysed outbreaks produced by these microorganisms, no attempt has been made to discriminate between these species (28, 30, 36); this study has thus been aimed at discriminating Acinetobacter baumannii by restricting intergenic spacer region PCR products.
Materiales y métodos
Bacterial strains. A total of 139 isolates were obtained from four Colombian hospitals during 2004, 2005, 2007 and 2009 (the hospitals were designated A-D). They were stored at -70°C in the Molecular Epidemiology Laboratory’s strainbank at the Instituto de Biotecnología, Universidad Nacional de Colombia; eighty-eight of the isolates (63.3%) were related to infection, a further 46 (33.1%) to colonisation and 5 (3.6%) were recovered from the clinical environment. The strains related to infection and colonisation were recovered from blood cultures (58/139), secretions (23/139), catheters (23/139) and urine (30/139). They had previously been identified as being A. baumannii-A. calcoaceticus complex by Vitek (Biomerieux, France) and all isolates (except one) were classified as being multi-resistant or resistant (8). Cefotaxime, ceftazidime, cefepime, imipenem, meropenem, ampicillin-sulbactam, piperacillin-tazobactam, ciprofloxacin, amikacin, gentamicin and trimethoprim-sulphametoxazole were the antibiotics evaluated in this study. Multi-resistant strains were considered as being those having exhibited resistance to at least three classes of antimicrobial agent. A. baumannii ATCC 19606 was used as RFLP-PCR control.
Amplifying the intergenic spacer region. DNA was obtained by cell lysis in distilled water from colonies grown for 18h at 37°C (33). The ITS was amplified in an iCycler thermocycler (BioRad, USA), using 1512F (5’GTCGTAACAAGGTAGCCGTA3’) and 6R (5’GGGTTYCCCCRTTCRGAAAT3’) primers at 62°C annealing temperature, as previously reported by Chang et al. (4). The products were visualised in 1% agarose gel electrophoresis and their sizes were estimated by comparison with a 100 bp DNA ladder (Invitrogen, San Diego, CA).
Restriction fragment length polymorphism (RFLP) PCR. The methodology established by Dolzani et al., was used for identifying A. baumannii according to ITS sequence (6). Briefly, in silico analysis led to selecting the Mbo I enzyme to distinguish restriction patterns for A. baumannii. The sequences used in the evaluation were those reported by Chang et al., which are available from GenBank (AY601820-AY601848) (4). Once the enzyme had been selected, amplicons from the isolates’ ITS were restricted, fragment patterns were analysed by 3.5% agarose gel electrophoresis (NuSieve FMC Bioproducts) and a photographic record was made (Gel-Doc BioRad). The ITS from 26 isolates were sequenced with ABI Prism 3730xI-PE (Applied Biosystems, Macrogen Inc.).
Molecular typing. The genetic structure of populations from hospitals A to D had been obtained in previous studies by repetitive extragenic palindromic PCR (REP-PCR); polyclonal populations and some clone groups were found (28, 29, 30). The genetic relationships amongst isolates identified as being A. baumannii were evaluated by REP-PCR typing, using REP IRI (5’IIICGICGICATCIGGC3’) and REP 2I (5’ICGICTTATCIGGCCTAC3’) primers and 46°C annealing temperature (34). PCR products were resolved by 2% agarose gel electrophoresis (4.6 V / cm) in 0.5 X TBE buffer for 2 hours and visualised with 1μg/mL ethidium bromide staining; the gels were photographed (Gel-Doc BioRad). The percentage of isolates’ electrophoretic profile similarity was estimated by using the Dice coefficient; cluster analysis was performed by using the unweighted pair-group method with arithmetic mean (UPGMA) algorithm and GelCompar II software (version 6.0) (Applied Maths, Sint-Martens-Latem, Belgium). Isolates having ≥75% similarity were considered to be clone groups.
Genospecies identification. The ITS region of 139 clinical isolates and the A. baumannii ATCC 19606 reference strain were amplified with 1512F and 6R primers (4). A 786 bp amplification product was obtained for each isolate studied here. All ITS obtained were analysed by restriction fragment length polymorphism (RFLP) to discriminate the Acinetobacter baumannii specie using the MboI enzyme which, according to in silico results, led to differentiating such specie from the others in the complex. As expected from in silico modelling and relative isolation frequency, 122 isolates displayed the 345, 327 49, 36 and 29 bp fragments corresponding to A. baumannii. The ITS from 26 isolates sequenced had 100% similarity with those deposited in Genbank for the A. baumannii specie. Genotyping. The dendrogram obtained with the 120 strains identified as being A. baumannii revealed 19 clonal groups, having 75% similarity (data not shown).
The genus Acinetobacter consists of 33 named and unnamed species. A. baumannii, A. calcoaceticus, Acinetobacter 13TU and Acinetobacter genomospecies 3 are phenotypically and genotypically similar, being frequently grouped as the A baumannii-A. calcoaceticus complex ( ABC); three of this complex’s members are frequently found in clinical samples. A. calcoaceticus is a soil microorganism which is rarely found in clinical samples. The complex has become important during the last few years due to the increase of outbreaks in hospitals and the fact that the strains involved are resistant to several antibiotics. Grouping the 4 species in the complex is inconvenient as this blurs the variations in each species’ biology and epidemiology. Identifying the complex’s species is thus important for ascertaining each one’s ecology, epidemiology and pathology (4, 16, 17, 31, 35).
Variations being observed in antimicrobial susceptibility, clinical manifestations and the outcome for patients suffering from invasive infections caused by different species from the complex have demonstrated the clinical importance of differentiating the complex’s species (35).
Dolzani proposed a method based on RFLP of the ITS in 1995 for identifying species from the complex using ALU1 and Nde 2 enzymes. However, Dolzani considered at the time that, in spite of its simplicity, it still could not be used in routine trials in clinical laboratories (6). This study has described a rapid and easy identification method based on restricting intergenic spacer region PCR products with which Ab can be differentiated from the other members of the complex, using just one restriction enzyme for digesting the ITS region and thereby providing an alternative for identifying A. baumannii species from genomic species within the A. baumannii-A. calcoaceticus complex which are difficult to identify by phenotypic identification systems (4). Given that many clinical laboratories now have the necessary equipment for using it, this method could be considered as an alternative for identifying Acinetobacter baumannii in such institutions.
One hundred and twenty of the 139 isolates previously identified as being A. baumannii by Vitek belonged to that species, suggesting that A. baumannii is the genospecies being most frequently isolated in hospitals (7, 20, 15, 22). Eighteen of the 19 isolates which were not identified as being A. baumannii by the method being used were identified as being A13 TU and the other one as Acinetobacter genomospecies 3 by ITS sequencing.
Great variability was found amongst isolates identified as A. baumannii. Two A. baumannii clonal groups were found to be distributed throughout hospitals A, B and D in Bogotá. Such distribution amongst the three hospitals in Bogotá could be explained by patient transfer between hospitals.
Hospital C had the greatest percentage of clonal groups; such A. baumannii variability within a single hospital could be explained by epidemic and sporadic clones’ coexistence (9, 23).
This work was supported by the Colombian Science, Technology and Innovation Department (COLCIENCIAS) grant 110145221066) and the Universidad Nacional de Colombia Research Division in Bogotá (DIB). We would like to thank María Ximena Rodríguez, Sandra Yamile Saavedra and Yamile Celis Bustos for their assistance with data analysis.
1 Bergogne-Bérézin, E; Towner, KJ. 1996. Acinetobacter spp. as a nosocomial pathogen: microbiological, clinical and epidemiological features. Clinical Microbiology Reviews 9(2):148-165 [ Links ]
2 Berlau, J., H. Aucken, H. Malnick, T. Pitt. 1999. Distribution of Acinetobacter species on skin of healthy humans. Eur J Clin Microbiol Dis.18:179-183. [ Links ]
3 Bouvet, P.J.M., P.A.D. Grimont. 1986. Taxonomy of the genus Acinetobacter with the recognition of Acinetobacter baumannii sp. nov., Acinetobacter haemolyticus sp. nov., Acinetobacter johnsonii sp. nov., and Acinetobacter junii sp. nov., and emended descriptions of Acinetobacter calcoaceticus and Acinetobacter lwoffii. International Journal of Systematic Bacteriology. 36(2): 228-240. [ Links ]
4 Chang, H.C., Y.F. Wei, L. Dijkshoorn, M. Vaneechoutte, C.T. Tang, T.C. Chang. 2005. Species level identification of isolates of the Acinetobacter calcoaceticus-Acinetobacter baumannii complex by sequence analysis of the 16S-23S rRNA gene spacer region. Journal of clinical microbiology. 43(4): 1632-1639. [ Links ]
5 Chen, C.C., L.J. Teng, T.C. Chang. 2004. Identification of clinically relevant viridians group streptococci by sequence analysis of the 16S-23S ribosomal DNA spacer region. Journal of Clinical Microbiology. 42(6):2651-2657 [ Links ]
6 Dolzani, L, E. Tonnin, C. Lagatolla, L. Prandin, C. Mony-Bragadin. 1995. Identification of Acinetobacter isolates in the A. calcoaceticus-A. baumannii complex by restriction analysis of the 16S-23S rRNA intergenic spacer sequences. Journal of Clinical Microbiology. 33(5):1108-1113 [ Links ]
7 Dominguez, M., G. Gonzalez, H. Bello, A. Garcia, S. Mella, M.E. Pinto, M.A. Martinez, R. Zemelman. 1995. Identification and biotyping of Acinetobacter spp. isolated in Chilean hospitals. Journal of Hospital Infection. 30: 267-271 [ Links ]
8 Falagas, M.E., P.K. Koletsi and I.A. Bliziotis. 2006. The diversity definitions of multidrug-resistant (MDR) and pandrug-resistant (PDR) Acinetobacter baumannii and Pseudomonas aeruginosa. Journal of Medical Microbiology. (55): 1619-1629. [ Links ]
9 Fernández-Cuenca, F., A. Pascual, A. Ribera, J. Vila, G. Bou, J.M., Cisneros, J. Rodríguez-Baño, J. Pachón, L. Martínez-Martínez and Grupo de Estudio de Infección Hospitalaria (GEIH). 2004. Diversidad clonal y sensibilidad a los antimicrobianos de Acinetobacter baumannii aislados en hospitales españoles. Estudio multicéntrico nacional: proyecto GEIH-Ab 2000. Enferm Infecc Microbiol Clin. 22(5):267-71 [ Links ]
10 Fujita, S. 2008. Internal transcribed spacer (ITS)-PCR identification of MRSA. Methods in Molecular Biology: MRSA protocols. 51-57 [ Links ]
11 García-Arata, M.I., P. Gerner-Smidt, F. Baquero, A. Ibrahim. 1997. PCR-Amplified 16S and 23S rDNA restriction analysis for the identification of Acinetobacter strains at the DNA group level. Res. Microbiol. 148:777-784. [ Links ]
12 García-Martínez, J., S.G. Acinas, A.I. Antón, F. Rodríguez-Valera. 1999. Use of the 16S-23S ribosomal genes spacer region in studies of prokaryotic diversity. Journal of Microbiological Methods. 36: 55-64 [ Links ]
13 Gerner-Smidt, P., I. Tjernberg. 1993. Acinetobacter in Denmark: II. Molecular studies of the Acinetobacter calcoaceticus-Acinetobacter baumannii complex. APMIS. 101: 826-832. [ Links ]
14 Giamarellou, H., A. Antoniadou, K. Kanellakopoulou. 2008. Acinetobacter baumannii: a universal threat to public health. International Journal of Antimicrobial Agents. 32:106-119. [ Links ]
15 Gundi, V.A.K.B., L. Dijkshoorn, S. Burignat, D. Raoult, B. La Scola. 2009. Validation of partial rpoB gene sequence analysis for the identification of clinically important and emerging Acinetobacter species. Microbiology. 155: 2333-2341. [ Links ]
16 Houang, T., S. Y. W. Chu, K. Y. Chu, K.C. Ng, C. M. Leung, and A. F.B. Cheng. 2003. Significance of genomic DNA group delineation in comparative studies of antimicrobial susceptibility of Acinetobacter spp. Antimicrobial Agents and Chemotherapy. 47(4): 1472-1475. [ Links ]
17 Hujer K.,M. A, A.M. Hujer, E.A. hulten, S. Bajaksouzian, J.M. Adams, C.J. Donskey, D.J. Ecker, C. Massire, M.W. Eshoo, R. Sampath, J. M. Thomson, P.N. Rather, D.W. Craft, J.T. Fishbain, A.J. Ewell, M.R. Jacobs, D.L. Paterson, R.A. Bonomo. 2006. Analysis of antibiotic resistance genes in multidrug-resistant Acinetobacter sp. isolates form military and civilian patients treated at the Walter Reed Army Medical Center. Antimicrobial Agents and Chemotherapy. 50(12): 4414-4123. [ Links ]
18 Kabadjova, P., X. Dousset, V. Le Cam, H. Prevost. 2002. Differentiation of closely related Carnobacterium food isolates based on 16S-23S ribosomal DNA intergenic spacer region polymorphism. Applied and Environmental Microbiology. 68(11): 5358-5366. [ Links ]
19 La Scola, B., V.A.K.B. Gundi, A. Kamis, D. Raoult. 2006. Sequencing of the rpoB gene and flanking spacers for molecular identification of Acinetobacter species. Journal of Clinical Microbiology. 44(3): 827-832 [ Links ]
20 Lim, Y.M., K.S. Shin, J. Kim. 2007. Distinct antimicrobial resistance patterns and antimicrobial resistance-harboring genes according to genomic species of Acinetobacter isolates. Journal of Clinical Microbiology. 45(3): 902-905 [ Links ]
21 Lin, YC, W.H. Sheng, S.C. Chang, J.T. Wang, Y.C. Chen, R.J. Wu, K.C. Hsia, S.Y. Li. 2008. Application of microsphere-based array for rapid identification of Acinetobacter spp. with distinct antimicrobial susceptibilities. Journal of Clinical Microbiology. 46(2):612-617 [ Links ]
22 Lyytikäinen, O., S. Köljalg, M. Härmä, J. Vuopio-Varkila. 1995. Outbreak caused by two multi-resistant Acinetobacter baumannii clones in a burns unit: emergence of resistance to imipenem. Journal of Hospital Infection. 31: 41-54 [ Links ]
23 Martín-Lozano, D., J.M. Cisneros, B. Becerril, L. Cuberos, T. Prados, C. Ortiz-Leyba, E. Cañas, J. Pachón. 2002. Comparison of repetitive extragenic palindromic sequence-based PCR method and clinical and microbiological methods for determining strain sources in case of nosocomial Acinetobacter baumannii bacteremia. Journal of Clinical Microbiology. 40(12): 4571-4574. [ Links ]
24 Mendoza, M., H. Meugnier, M. Bes, J. Etienne, J. Freney. 1998. Identification of Staphylococcus species by 16S-23S rDNA intergenic spacer PCR analysis. International Journal of Systematic Bacteriology. 48:1049-1055. [ Links ]
25 Misbah, S., H. Hassan, M.Y. Yusof, Y.A. Hanifah, S. AbuBakar. 2005. Genomic species identification of Acinetobacter of clinical isolates by 16S rDNA sequencing. Singapore Med J. 46(9): 461-464. [ Links ]
26 Nagpal, M.L., K.F. Kox, A. Fox. 1998. Utility of 16S-23S rRNA spacer region methodology: how similar are interspace regions within a genome and between strains for closely related organisms? Journal of Microbiological Methods. 33:211-219 [ Links ]
27 Nowak, A., J. Kur. 1996. Differentiation of seventeen genospecies of Acinetobacter by multiplex polymerase chain reaction and restriction length polymorphism analysis. Mol. Cell. Probes. 10: 405-411 [ Links ]
28 Orquídea, J., J.R. Mantilla, E.M. Valenzuela, F. Fernández, C.A. Álvarez, E.J. Osorio. 2006. Caracterización molecular de aislamientos de Acinetobacter baumannii provenientes de la unidad de quemados de un hospital de tercer nivel de Bogotá. Infectio 10(2): 71-78 [ Links ]
29 Reboli, A.C., E.D. Houston, J.S. Monteporte, C.A. Wood, R.J. Hamill. 1994. Discrimination of epidemic and sporadic isolates of Acinetobacter baumannii by repetitive element PCR-mediated DNA fingerprinting. Journal of Clinical Microbiology. 32(11): 2635-2640. [ Links ]
30 Saavedra, S.Y.; J.C. Nuñez, I.Y. Pulido, E.B. González, E.M. Valenzuela, M.T. Reguero, J.R. Mantilla, A.I. Arango, P. Bravo. 2008. Characterization of carbapenem-resistant Acinetobacter calcoaceticus-A. baumannii complex isolates in a third-level hospital in Bogotá, Colombia. International Journal of Antimicrobial Agents. 31:389-391. [ Links ]
31 Towner, KJ. 2002. Acinetobacter. Dissemination Bacterial Infections. University Hospital, Nottingham, UK. 987-998 [ Links ]
32 Tyrrell, G.J., R.N. Bethune, B. Willey, D.E. Low. 1997. Species identification of Enterococci via intergenic ribosomal PCR. Journal of Clinical Microbiology. 35(5):1054-1060. [ Links ]
33 Vaneechoutte, M., L. Dijkshoorn, I. Tjernberg, A. Elaichouni, P. De Vos, G. Claeys, G. Verschraegen. 1995. Identification of Acinetobacter genomic species by amplified ribosomal DNA restriction analysis. Journal of Clinical Microbiology. 33(1):11-15. [ Links ]
34 Versalovic, J., T. Koeuth, J.R. Lupski. 1991. Distribution of repetitive DNA sequences in eubacteria and application to fingerprinting of bacterial genomes. Nucleic Acids Research. 19(24): 6823-6831 [ Links ]
35 Vila, J., M.A. Marcos, M.T. Jiménez de Anta. 1996. A comparative study of different PCR-based DNA fingerprinting techniques for typing of the Acinetobacter calcoaceticus-A. baumannii complex. J. Med. Microbiol. 44: 482-489 [ Links ]
36 Villegas, M.V., J.N. Kattan, A. Correa, K. Lolans, A.M. Guzman, N. Woodford, D. Livermore, J.P. Quinn and the Colombian Nosocomial Bacterial Resistance Study Group. 2007. Dissemination of Acinetobacter baumannii clones with OXA-23 carbapenemase in Colombian hospitals. Antimicrobial Agents and Chemotherapy. 51(6): 2001-2004 [ Links ]